Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Auditor change
Asset disposition
Quarterly results
CC transcript
|
|
ACADIA PHARMACEUTICALS INC (ACAD)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/06/2023 |
4
| KIM AUSTIN D. (EVP,General Counsel, Secretary) has filed a Form 4 on ACADIA PHARMACEUTICALS INC|
Txns:
| Sold 16,369 shares
@ $21.96, valued at
$359.5k
Exercised 36,174 restricted stock units
@ $0 |
|
| 10/06/2023 |
4
| DAVIS STEPHEN (CEO) has filed a Form 4 on ACADIA PHARMACEUTICALS INC|
Txns:
| Exercised 103,999 shares
@ $0
Sold 51,563 shares
@ $21.96, valued at
$1.1M
Exercised 103,999 restricted stock units
@ $0 |
|
| 08/23/2023 |
4
| Schneyer Mark C. (EVP, CFO) has filed a Form 4 on ACADIA PHARMACEUTICALS INC|
Txns:
| Sold 10,000 shares
@ $28.997, valued at
$290k
|
|
| 07/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/13/2023 |
4
| DAVIS STEPHEN (CEO) has filed a Form 4 on ACADIA PHARMACEUTICALS INC|
Txns:
| Sold 16,498 shares
@ $25, valued at
$412.5k
Sold 55,104 shares
@ $25.0517, valued at
$1.4M
|
|
| 06/16/2023 |
4
| Kihara James (Principal Accounting Officer) has filed a Form 4 on ACADIA PHARMACEUTICALS INC|
Txns:
| Sold 2,000 shares
@ $24.15, valued at
$48.3k
|
|
| 06/12/2023 |
4
| Schneyer Mark C. (EVP, CFO) has filed a Form 4 on ACADIA PHARMACEUTICALS INC|
Txns:
| Sold 974 shares
@ $25.02, valued at
$24.4k
Exercised 1,893 restricted stock units
@ $0 |
|
| 06/05/2023 |
4
| BAKER BROS. ADVISORS LP (10% Owner) has filed a Form 4 on ACADIA PHARMACEUTICALS INC|
Txns:
| Granted 13,304 shares
@ $0
Granted 22,090 options to buy
@ $23.9, valued at
$528k
|
|
| 05/24/2023 |
4
| BAKER BROS. ADVISORS LP (10% Owner) has filed a Form 4 on ACADIA PHARMACEUTICALS INC|
Txns:
| Bought 7,645 shares
@ $24.4604, valued at
$187k
Bought 82,148 shares
@ $24.4604, valued at
$2M
Bought 3,781 shares
@ $24.8, valued at
$93.8k
Bought 40,632 shares
@ $24.8, valued at
$1M
Bought 10,858 shares
@ $25.3302, valued at
$275k
Bought 116,672 shares
@ $25.3302, valued at
$3M
Bought 6,941 shares
@ $25.54, valued at
$177.3k
Bought 74,582 shares
@ $25.54, valued at
$1.9M
Bought 20,304 shares
@ $25.2723, valued at
$513.1k
Bought 218,171 shares
@ $25.2723, valued at
$5.5M
Bought 2,688 shares
@ $25.5138, valued at
$68.6k
|
|
| 05/19/2023 |
4
| Kihara James (Principal Accounting Officer) has filed a Form 4 on ACADIA PHARMACEUTICALS INC|
Txns:
| Sold 5,947 shares
@ $22.5, valued at
$133.8k
Exercised 5,947 restricted stock units
@ $0 |
|
| 05/19/2023 |
4
| Schneyer Mark C. (EVP, CFO) has filed a Form 4 on ACADIA PHARMACEUTICALS INC|
Txns:
| Sold 15,310 shares
@ $22.5, valued at
$344.5k
Exercised 14,869 restricted stock units
@ $0 |
|
| 05/19/2023 |
4
| Teehan Brendan (EVP, COO, Head of Commercial) has filed a Form 4 on ACADIA PHARMACEUTICALS INC|
Txns:
| Sold 14,869 shares
@ $22.5, valued at
$334.6k
Exercised 14,869 restricted stock units
@ $0 |
|
| 05/03/2023 |
4
| Teehan Brendan (EVP, COO, Head of Commercial) has filed a Form 4 on ACADIA PHARMACEUTICALS INC|
Txns:
| Granted 89,936 options to buy
@ $21.75, valued at
$2M
Granted 27,259 restricted stock units
@ $0 |
|
| 05/03/2023 |
4
| DAVIS STEPHEN (CEO) has filed a Form 4 on ACADIA PHARMACEUTICALS INC|
Txns:
| Granted 295,503 options to buy
@ $21.75, valued at
$6.4M
Granted 89,564 restricted stock units
@ $0 |
|
| 05/03/2023 |
4
| Schneyer Mark C. (EVP, CFO) has filed a Form 4 on ACADIA PHARMACEUTICALS INC|
Txns:
| Granted 89,936 options to buy
@ $21.75, valued at
$2M
Granted 27,259 restricted stock units
@ $0 |
|
| 05/03/2023 |
4
| KIM AUSTIN D. (EVP,General Counsel, Secretary) has filed a Form 4 on ACADIA PHARMACEUTICALS INC|
Txns:
| Granted 59,957 options to buy
@ $21.75, valued at
$1.3M
Granted 18,172 restricted stock units
@ $0 |
|
| 05/03/2023 |
4
| Kihara James (Principal Accounting Officer) has filed a Form 4 on ACADIA PHARMACEUTICALS INC|
Txns:
| Granted 17,131 options to buy
@ $21.75, valued at
$372.6k
Granted 10,384 restricted stock units
@ $0 |
|
| 05/02/2023 |
4
| KIM AUSTIN D. (EVP,General Counsel, Secretary) has filed a Form 4 on ACADIA PHARMACEUTICALS INC|
Txns:
| Sold 917 shares
@ $21.18, valued at
$19.4k
Exercised 3,005 restricted stock units
@ $0 |
|
| 05/02/2023 |
4
| Teehan Brendan (EVP, COO, Head of Commercial) has filed a Form 4 on ACADIA PHARMACEUTICALS INC|
Txns:
| Sold 548 shares
@ $21.18, valued at
$11.6k
Exercised 1,567 restricted stock units
@ $0 |
|
| 05/02/2023 |
4
| DAVIS STEPHEN (CEO) has filed a Form 4 on ACADIA PHARMACEUTICALS INC|
Txns:
| Sold 7,806 shares
@ $21.18, valued at
$165.3k
Exercised 15,625 restricted stock units
@ $0 |
|
| 02/27/2023 |
4
| Kihara James (Principal Accounting Officer) has filed a Form 4 on ACADIA PHARMACEUTICALS INC|
Txns:
| Sold 350 shares
@ $18.78, valued at
$6.6k
Exercised 840 restricted stock units
@ $0 |
|
| 02/27/2023 |
4
| Schneyer Mark C. (EVP, CFO) has filed a Form 4 on ACADIA PHARMACEUTICALS INC|
Txns:
| Sold 577 shares
@ $18.78, valued at
$10.8k
Exercised 1,353 restricted stock units
@ $0 |
|
| 02/27/2023 |
4
| DAVIS STEPHEN (CEO) has filed a Form 4 on ACADIA PHARMACEUTICALS INC|
Txns:
| Sold 3,851 shares
@ $18.78, valued at
$72.3k
Exercised 10,945 restricted stock units
@ $0 |
|
| 02/27/2023 |
4
| KIM AUSTIN D. (EVP,General Counsel, Secretary) has filed a Form 4 on ACADIA PHARMACEUTICALS INC|
Txns:
| Sold 803 shares
@ $18.78, valued at
$15.1k
Exercised 2,214 restricted stock units
@ $0 |
|
| 02/27/2023 |
4
| Teehan Brendan (EVP, COO, Head of Commercial) has filed a Form 4 on ACADIA PHARMACEUTICALS INC|
Txns:
| Sold 461 shares
@ $18.78, valued at
$8.7k
Exercised 1,107 restricted stock units
@ $0 |
|
| 02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/13/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/10/2023 |
4
| DAVIS STEPHEN (CEO) has filed a Form 4 on ACADIA PHARMACEUTICALS INC|
Txns:
| Sold 3,904 shares
@ $17.1303, valued at
$66.9k
Exercised 9,528 restricted stock units
@ $0 |
|
| 01/10/2023 |
4
| Teehan Brendan (EVP, COO, Head of Commercial) has filed a Form 4 on ACADIA PHARMACEUTICALS INC|
Txns:
| Sold 532 shares
@ $17.1303, valued at
$9.1k
Exercised 1,286 restricted stock units
@ $0
Exercised 1,286 restricted stock units
@ $0 |
|
| 01/10/2023 |
4
| KIM AUSTIN D. (EVP,General Counsel, Secretary) has filed a Form 4 on ACADIA PHARMACEUTICALS INC|
Txns:
| Sold 589 shares
@ $17.1303, valued at
$10.1k
Exercised 1,633 restricted stock units
@ $0 |
|
| 11/22/2022 |
4
| Stankovic Srdjan R. (President) has filed a Form 4 on ACADIA PHARMACEUTICALS INC|
Txns:
| Exercised 6,250 shares
@ $0
Sold 1,847 shares
@ $15.07, valued at
$27.8k
Exercised 6,250 restricted stock units
@ $0 |
|
| 10/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|